Eris Lifesciences Ltd Financial Overview
Eris Lifesciences Ltd's market cap is currently ₹212.22B. The company's EPS TTM is ₹8.8; its P/E ratio is 51.04; and it has a dividend yield of 0.47%. Eris Lifesciences Ltd is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ₹10.40. See an overview of income statement, balance sheet, and cash flow financials.
